Speaker Profile
M.D., Ph.D., Head of Clinical Trials and Medical Information, Labcorp Genetics
Biography
Dr. Esplin is board certified in clinical genetics and internal medicine with a focus on using comprehensive germline, ctDNA and solid-tumor somatic genomic information to provide cancer patients precision therapies and clinical trials access. This includes the landmark INTERCEPT study with Mayo Clinic on universal germline testing in all patients with cancer; the PROCLAIM study demonstrating the utility of universal genetic testing for patients with prostate cancer; and ARTEMIS-PC on ctDNA-MRD detection in patients with pancreatic cancer, among others. Dr. Esplin completed the MSTP program at UT Southwestern obtaining his MD and PhD in genetics. Clinical genetics training at Stanford University was followed by an NIH-funded Tashia and John Morgridge Endowed Postdoctoral Fellowship under Mike Snyder in the Stanford Department of Genetics, where he maintains an academic appointment. He is a fellow of the American College of Medical Genetics and Genomics (ACMG) and the American College of Physicians (ACP).
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Edward Esplin, Invitae
- PMWC Award Ceremony
Pioneer Honoree: Michael Snyder, Stanford
Pioneer Honoree: Kári Stefánsson, deCode Genetics
- Keynote
- Kári Stefánsson, deCode Genetics - Genomic & Multiomic Intervention and Prevention of Disease: Colorectal Cancer
- Edward Esplin, Labcorp Genetics - Multi-omic Characterization of Cancer Development and Progression
Chair: Kathleen Barnes, Oxford Nanopore Tech
- Carol Greider, UCSC
- Orit Rozenblatt-Rosen, Genentech
- Emily Leproust, Twist Biosciences - Imaging and Data Strategies in the Human Tumor Atlas Network (HTAN)
- Sean Hanlon, NIH/HTAN
- Advanced Image Analysis and Data Integration in the Human BioMolecular Atlas Program (HuBMAP)
- Pinaki Sarder, University of Florida - Predicting Disease and Managing Health Through Wearables Technologies (PANEL)
Chair: Michael Snyder, Stanford
- Jessilyn Dunn, Duke
- Noosheen Hashemi, January.ai
- Gil Levy, Assuta Ashdod Hospital - Protein Scoring Empowers Improved Disease Risk Prediction
- Cindy Lawley, Olink
- Multi-omic Interrogation of Organ Systems
Chair: Jessilyn Dunn, Duke
- Gloria Pryhuber, University of Rochester Medical Center
- Chenchen Zhu, Stanford
- Assaf Kacen, PromiseBio - Harnessing Single-Cell Genomics for Precision Disease Intervention
- Ben Hindson, 10x Genomics - Vision for Tomorrow: Pioneer Insights (Audience Qs)
Chair: Cindy Lawley, Olink
- Kári Stefánsson, deCode Genetics
